有机化学人才网 | 最新人才 | 最新职位 | 技术交易 | 药物合成 |
   
全站搜索: |
  您当前位置:网站首页 >> 药物合成路线图解
 

药物详细合成路线

Name Iguratimod;T-614;Careram
Chemical Name 3-(Formylamino)-7-(methylsulfonamido)-6-phenoxy-4H-1-benzopyran-4-one
CAS 123663-49-0
Related CAS
Formula C17H14N2O6S
Structure
Formula Weight 374.37493
Stage 预注册
Company Toyama (Originator), Dong-A (Licensee), Eisai (Licensee)
Activity/Mechanism Antiarthritic Drugs, Disease-Modifying Drugs, Rheumatoid Arthritis, Treatment of, TREATMENT OF MUSCULOSKELETAL & CONNECTIVE TISSUE DISEASES, NF-kappaB (NFKB) Activation Inhibitors
Syn. Route 2
Route 1
the reduction of 3-nitro-4-phenoxyphenol (i) with fe, aqueous hcl gives 3-amino-4-phenoxyphenol (ii), which is acylated with methanesulfonyl chloride by means of pyridine in dichloromethane affording 3-(methylsulfonamido)-4-phenoxyphenol (iii). the condensation of (iii) with 3-chloropropionic acid (iv) by means of naoh in water gives 3-[3-(methylsulfonamido)-4-phenoxyphenoxy]propionic acid (v), which is cyclized by means of polyphosphoric acid at 65-70 c yielding 7-(methylsulfonamido)-6-phenoxy-3,4-dihydro-2h-1-benzopyran-4-one (vi). the bromination of (vi) with br2 in chcl3 affords 3-bromo-7-(methylsulfonamido)-6-phenoxy-3,4-dihydro-2h-1-benzopyran-4-one (vii), which is treated with sodium azide in dmf at 70-75 c giving 3-amino-7-(methylsulfonamido)-6-phenoxy-2h-1-benzopyran-4-one (viii). finally, this compound is formylated with formic acid in acetic anhydride.
List of intermediates No.
6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline; 6-methoxy-1,2,3,4-tetrahydro-7-isoquinolinyl methyl ether (i)
7-methoxy-1,2,3,4-tetrahydro-6-isoquinolinol (ii)
2-(3,4-dimethoxyphenyl)-7-[6-hydroxy-7-methoxy-3,4-dihydro-2(1h)-isoquinolinyl]-2-[(4-methylphenyl)sulfanyl]heptanenitrile (iii)
7-[6-(2-chloroethoxy)-7-methoxy-3,4-dihydro-2(1h)-isoquinolinyl]-2-(3,4-dimethoxyphenyl)-2-[(4-methylphenyl)sulfanyl]heptanenitrile (iv)
5-bromo-2-methyl-7-nitro-1,2,3,4-tetrahydro-8-isoquinolinylamine; 5-bromo-2-methyl-7-nitro-1,2,3,4-tetrahydro-8-isoquinolinamine (v)
ethyl 2-amino-5-bromo-3-nitro-6-vinylbenzyl(methyl)carbamate (vi)
ethyl 2,3-diamino-6-ethylbenzyl(methyl)carbamate (vii)
(6-ethyl-2,3-dioxo-1,2,3,4-tetrahydro-5-quinoxalinyl)methyl(methyl)carbamic acid (viii)
Reference 1:
    takano, s.; yoshida, c.; inaba, t.; tanaka, k.; takeno, r.; nagaki, h.; shimotori, t.; makino, s. (toyama chemical co., ltd.); 4h-benzopyran-4-one derivs. and their salts, their processes of production and pharmaceutical compsns. containing them. au 8823489; ch 679397; fr 2621585; gb 2210879; jp 1995267943; us 4954518 .
Reference 2:
    mealy, n.; prous, j.; castaner, j.; t-614. drugs fut 1993, 18, 8, 714.

Route 2
a preparative-scale synthetic route for t-614 has been reported:the reaction of 4-chloro-3-nitroanisole (i) with potassium phenolate in hot dmf gives 4-phenoxy-3-nitroanisole (ii), which is reduced to the corresponding 3-amino compound (iii) by treatment with fe and hcl. the reaction of (iii) with mesyl chloride in pyridine affords the sulfonamide (iv), which is acylated with 2-aminoacetonitrile (v) and alcl3 in nitrobenzene/hcl giving the 2-aminoacetophenone (vi). formylation of (vi) at the nh2 with acetic formic anhydride yields the formamide (vii), which is demethylated with alcl3 and nai in acetonitrile affording the phenol (viii). finally, this compound is cyclized with dimethylformamide dimethylacetal in dmf.
List of intermediates No.
2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1h-indol-3-yl]acetyl chloride (ix)
1-[4-(tert-butyl)phenyl]-n-[(2s)-2-(4-methylphenyl)propyl]-5-oxo-3-pyrrolidinecarboxamide (i)
(2r,3r,4s)-4-(1,3-benzodioxol-5-yl)-1-(tert-butoxycarbonyl)-2-(3-fluoro-4-methylphenyl)-3-pyrrolidinecarboxylic acid (ii)
ethyl (2r,3r,4s)-4-(1,3-benzodioxol-5-yl)-2-(3-fluoro-4-methylphenyl)-3-pyrrolidinecarboxylate (iii)
ethyl (2r,3r,4s)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(3-fluoro-4-methylphenyl)-3-pyrrolidinecarboxylate (iv)
1-(4-pyridinyl)-4-piperidinecarbaldehyde (vi)
(vii)
(viii)
n-(2-aminoethyl)-2-bromo-n-{[1-(4-pyridinyl)-4-piperidinyl]methyl}acetamide (v)
Reference 1:
    yoshida, c.; tanaka, k.; nagaki, h.; takeno, r.; inaba, t.; takano, s.; synthesis and antiinflammatory activities of 7-methanesulfonylamino-6-phenoxychromones. antiarthritic effect of the 3-formylamino compound (t-614) in chronic inflammatory disease models. chem pharm bull 2000, 48, 1, 131.

来源:药化网

作者:药化小编

摘要:本文合成路线介绍的是药物中文名艾拉莫德;英文名Iguratimod;T-614;Careram;CAS[123663-49-0]

 
推荐VIP企业
无锡景耀生物科技有限公司
杭州卢普生物科技有限公司
宁波赛伦化工有限公司
苏州昊赛生物科技有限公司
北京嘉盛扬医药科技有限公司
上海泽涵生物医药科技有限公司
河北固安三利化工公司
郑州凯普瑞生物技术有限公司
上海药谷药业有限公司
兰州康寓信生物科技有限公司
湖北朗昕生化药业有限公司
武汉福鑫化工有限公司
嘉兴市英南化工有限公司
苏州迪飞医药科技有限公司
唐山盛源泽兴化工有限公司
上海盛中医药化工有限公司
连云港天和化学有限公司
南京晨瑞医药科技有限公司
南京苏如化工有限公司
常州瑞盛化工有限公司
热门文章
作物保护领域新热点——植物生物
海利尔获“金质量·持续成长奖”
简析甲氧基丙烯酸酯类杀菌剂登记
辉丰公示原药车间停产进展,山东
诺华MEK/BRAF国内价格不
化学、生物化学及微生物农药制造
供应、需求、出口——全方位了解
我国农药产品质量情况统计分析
第15批!通过认定的农药登记试
2019农业令人瞩目十大事件!
先正达受让中化、中化工农业板块
麦田杂草发生加重,春季化除压力
土壤调理剂市场规模已达482亿
呋虫胺市场现状与未来展望
预计小麦重大病虫害总体偏重发生
从应用现状看市场发展:小麦田除
2020年重大病虫害发生将重于
全球食品安全指数:中国进步明显
历时一年,由南向北,草地贪夜蛾
全球作物保护行业发展趋势
 友情链接
有机化学人才网  
首页 | 广告服务 | 建站服务 | 关于我们 | 联系我们 | 版权声明